학술논문

New Delhi metallo-[beta]-lactamase-1: local acquisition in Ontario, Canada, and challenges in detection
Document Type
Report
Source
CMAJ: Canadian Medical Association Journal. August 9, 2011, Vol. 183 Issue 11, p1257, 5 p.
Subject
Canada
Language
English
ISSN
0820-3946
Abstract
New Delhi metallo-[beta]-lactamase-1 (NDM-1) is a recently identified metallo-[beta]-lactamase that confers resistance to carbapenems and all other [beta]-lactam antibiotics, with the exception of aztreonam. NDM-1 is also associated with resistance to many other classes of antibiotics. The enzyme was first identified in organisms isolated from a patient in Sweden who had previously received medical treatment in India, but it is now recognized as endemic throughout India and Pakistan and has spread worldwide. The gene encoding NDM-1 has been found predominantly in Escherichia coli and Klebsiella pneumoniae. We describe the isolation NDM-1-producing organisms from two patients in Toronto, Ontario. To the best of our knowledge, this is the first report of an organism producing NDM-1 that was locally acquired in Canada. We also discuss the evidence that NDM-1 can affect bacterial species other than E. coli and K. pneumoniae, the limited options for treatment and the difficulty laboratories face in detecting organisms that produce NDM-1.
New Delhi metallo-[beta]-lactamase-1 (NDM1) is a metallo-[beta]-lactamase that confers resistance to carbapenems and all other [beta]-lactam antibiotics, with the exception of aztreonam. It is predominantly found in the Enterobacteriaeceae. It [...]